Status:

NOT_YET_RECRUITING

Effects of taVNS on Fibromyalgia Pain

Lead Sponsor:

Spaulding Rehabilitation Hospital

Conditions:

Fibromyalgia, Pain

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Transauricular vagus nerve stimulation (taVNS) is a newer delivery system, using a non-invasive stimulation device placed at the ear's concha. TaVNS is a portable, safe, and low-cost intervention, and...

Eligibility Criteria

Inclusion

  • Older than 18 years old.
  • Diagnosis of FM pain according to the American College of Rheumatology (ACR) 2010 criteria (existing pain for more than six months with an average of at least 3 on a 0-10 VAS scale).
  • must have the ability to feel sensation by Von-Frey fiber on the forearm.
  • Able to provide informed consent to participate in the study.

Exclusion

  • Subjects who have unstable medical conditions (e.g., uncontrolled diabetes, uncompensated cardiac issues, heart failure, or chronic obstructive pulmonary disease) or who have functional deficits, as self-reported.
  • history of substance abuse within the past six months as self-reported (if the subject reports a history of substance abuse, we will confirm using the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) criteria).
  • Presence of implanted cranial electronic medical devices (e.g., cochlear implants).
  • pregnancy (as the safety of taVNS in the pregnant population (and children) has not been assessed (though the risk is non-significant), we will exclude pregnant women (and children). Women of child-bearing potential will be required to take a urine pregnancy test during the screening process and every two weeks of stimulation).

Key Trial Info

Start Date :

June 1 2026

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2029

Estimated Enrollment :

152 Patients enrolled

Trial Details

Trial ID

NCT06193317

Start Date

June 1 2026

End Date

May 1 2029

Last Update

September 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Spaulding Hospital Cambridge

Cambridge, Massachusetts, United States, 02138